Skip to main content

Brattleboro Back Into Opioid Negotiating Class

Brattleboro Back Into Opioid Negotiating Class

Brattleboro Back Into Opioid Negotiating Class

Introduction

On Tuesday, the Brattleboro Selectboard decided to move back into an opioid national negotiating class,  after opting out a week ago.

The class, which includes every town, city, and county in the country, is formed to seek comprehensive settlements with drug companies, distributors, and pharmacy chains involved in the lawsuit. In the meantime, the town will also proceed with an individual lawsuit.

The class includes more than 34,000 potential class members, managed by 49 counties and cities serving as class representatives, negotiating with up to 13 corporate defendants.

The members of the class have the right to vote on any proposed settlement with a majority of 75 percent approval. Also, being a part of the class will not prevent a town or city from bringing its own lawsuit, and a municipality can’t collect twice from the same defendant.

Companies manufacturing opioids convinced the medical community that these medications were not addictive and were purely beneficial. This belief raised the number of prescriptions and sales unwarrantedly, resulting in a mass misuse of these drugs, to the extent that this was identified by the U.S. Food and Drug Administration (FDA) as a public issue and named it an opioid crisis.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!